Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Climb Bio, Inc.
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
September 04, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 12, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
June 18, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
May 14, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
April 01, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
ABOS
ASX:IMU
CLYM
LENZ
SLDB
VERV
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
March 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at Upcoming Investor Conferences
February 25, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
February 24, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
January 09, 2025
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 19, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at Upcoming Investor Conferences
October 31, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
October 15, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024
October 11, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
October 04, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Climb Bio to Host Virtual Investor Event on October 15, 2024
October 03, 2024
From
Climb Bio, Inc.
Via
GlobeNewswire
Tickers
CLYM
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit